Frontotemporal dementia treatment: a review

Authors

  • Samreen Ahmed Department of Psychiatry, University of Illinois at Chicago,Chicago, IL, USA

DOI:

https://doi.org/10.18203/2319-2003.ijbcp20162424

Keywords:

FTD, FTD treatment, AChE inhibitors

Abstract

Frontotemporal Dementia is characterized by social and behavioural symptoms, in addition to aphasia. FTD, being the fourth most common cause of dementia, is mostly prevalent in younger population. FTD is diagnosed clinically. The various pharmacological treatment options are antidepressants, cholinesterase inhibitors, and mood stabilizers. Sometimes, nursing, and psychotherapy can also be implemented.

References

Frontotemporal dementia: Clinical features and diagnosis. Available from: uptodate.com.

Banks S, Weintraub S. Self-awareness and self-monitoring of cognitive and behavioral deficits in behavioral variant frontotemporal dementia, primary progressive aphasia and probable Alzheimer's disease. Brain Cogn. 2008;67(1):58-68.

Frontotemporal dementia: treatment. Available from: uptodate.com.

Kelley BJ, Boeve BF, Josephs KA. Young-onset dementia: demographic and etiologic characteristics of 235 patients. Arch Neurol. 2008;65:1502-08.

Graff-Radford NR, Woodruff BK. Frontotemporal dementia. Semin Neurol. 2007;27(1):48-57.

Hodges JR, Davies R, Xuereb J, Kril J, Halliday G. Survival in frontotemporal dementia. Neurology. 2003;61(3):349-54.

Harvey RJ, Skelton-Robinson M, Rossor MN. The prevalence and causes of dementia in people under the age of 65 years. J Neurol Neurosurg Psychiatr. 2003;74:1206-09.

Srikanth S, Nagaraja AV, Ratnavalli E. Neuropsychiatric symptoms in dementia-frequency, relationship to dementia severity and comparison in Alzheimer's disease, vascular dementia and frontotemporal dementia Neurol Sci. 2005;236(1-2):43-8.

Banks S, Weintraub S. Self-awareness and self-monitoring of cognitive and behavioral deficits in behavioral variant frontotemporal dementia, primary progressive aphasia and probable Alzheimer's disease. Brain Cogn. 2008;67(1):58-68.

Barrett AM, Chawla J. Medscape. Pick disease. Available at http://emedicine.medscape.com/article/1135504-overview#aw2aab6b2b4

Haugarvoll K, Wszolek ZK, Hutton M. The genetics of frontotemporal dementia. Neurol Clin. 2007;25(3):697-715.

Wider C, Wszolek ZK. Etiology and pathophysiology of frontotemporal dementia, parkinson disease and alzheimer disease: lessons from genetic studies. Neurodegenerative Dis. 2008;5:122-5.

Rascovsky K, Grossman M. Clinical diagnostic criteria and classification controversies in frontotemporal lobar degeneration. Int Rev Psychiatry. 2013;25(2):145-58.

Madhusoodanan S, Ting MB. Pharmacological management of behavioral symptoms associated with dementia. World J Psychiatry. 2014;4(4):72-9.

Wylie MA, Shnall A, Onyike CU, Huey ED. Management of Frontotemporal Dementia in Mental Health and Multidisciplinary Settings. Int Rev Psychiatry. 2013;25(2):230-6.

Downloads

Published

2017-01-05

How to Cite

Ahmed, S. (2017). Frontotemporal dementia treatment: a review. International Journal of Basic & Clinical Pharmacology, 5(4), 1179–1180. https://doi.org/10.18203/2319-2003.ijbcp20162424

Issue

Section

Review Articles